VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > BSEcho 2024 see Ventripoint now FDA 4.0 and Sales news ?

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Sep 23, 2024 12:28pm

89 Views

Post# 36236585

BSEcho 2024 see Ventripoint now FDA 4.0 and Sales news ?

Interesting see Ventripoint now $$$

Not registered for conference yet? If you're planning to attend virtually, we've made important changes to registration - find out more here: https://ow.ly/ki2n50TsY9g